Skip to main content
Premium Trial:

Request an Annual Quote

Caris Life Sciences: Mike Weinstein

Caris Life Sciences has appointed Mike Weinstein as its executive vice president and chief financial officer. Prior to joining the company, Weinstein served as senior VP of strategy at Medtronic and was a member of the company's executive committee. Before working at Medtronic he was a managing director at JPMorgan Chase, leading the firm's equity research healthcare group. Weinstein is a graduate of Georgetown University and serves on the board of advisors for the university's McDonough School of Business.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.